ANNOUNCEMENT

Save $150 on MedCity CONVERGE Healthcare Innovation Summit July 9-10 in Philadelphia. Offer ends July 8..

Topic: PRX

Par Pharmaceuticals’ generic appeal attracts $1.9 billion private equity offer

Par Pharmaceuticals’ generic appeal attracts $1.9 billion private equity offer

July 17, 2012 3:43 pm by | 0 Comments

Generics producer Par Pharmaceuticals (NYSE: PRX) has been snapped up by a global private equity firm TPG in a deal that values the company at $1.9 billion, the tenth largest ... Read more
Par Pharmaceuticals completes third generics deal in 5 months

Par Pharmaceuticals completes third generics deal in 5 months

February 17, 2012 5:58 pm by | 0 Comments

Par Pharmaceuticals (NYSE: PRX) completed its third generics deal in six months with the $20.5 million acquisition of a drug developer and manufacturer based in India.Edict Pharmaceuticals has 11 abbreviated ... Read more